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Nanoparticles for Fidgety Cell
Movement and Enhanced Wound
Healing
Ivan Jozic1, Sylvia Daunert2,3, Marjana Tomic-Canic1 and Irena Pastar1
Complex spatiotemporal interaction of Rho GTPases with microtubules (MTs)
and MT-associated proteins drives directed cellular migration. In this issue,
Charafeddine et al. describe a role for a novel MT-severing enzyme, ﬁdgetin-like
2 (FL2), in directional migration of keratinocytes and ﬁbroblasts. FL2 normally
localizes to the leading edge of the cell cortex where it shears MTs, thus dictating
the size and distribution of focal adhesions by regulating cytoskeletal remodel-
ing. Small interfering RNA (siRNA)–directed knockdown of FL2 increases cell
migration and focal adhesion area in vitro through possible interaction with Rho
GTPases. Efﬁcient FL2 knockdown in murine wounds was achieved using
nanoparticles as a siRNA delivery vehicle, and this resulted in enhanced wound
closure in vivo. Effective siRNA nanoparticle targeting of MT-severing enzymes
offers promise of controlled and targeted delivery that may maximize
therapeutic success for patients with burn wounds and chronic wound disorders.
Journal of Investigative Dermatology (2015) 135, 2151–2153; doi:10.1038/jid.2015.237
Directed cell migration of epidermal
keratinocytes and dermal ﬁbroblasts is
an essential and a highly regulated
process during cutaneous wound heal-
ing (Eming et al., 2014, Pastar et al.,
2014). Therefore, it should be no
surprise that mechanisms affecting cyto-
skeletal remodeling have attracted a
great deal of attention in the attempts
to understand how regulation of micro-
tubules and actin microﬁlaments leads
to directed cell migration, cell adhe-
sion, and wound closure (Charafeddine
et al., 2015). Our traditional under-
standing of cellular migration is based
on the groundbreaking work of Hall
et al. (Hall, 1992), who identiﬁed three
key members of Rho GTPases (RhoA,
Rac1 and Cdc42) and elucidated how
they regulate cytoskeletal assembly
during cell movement. Rapid and
localized recruitment of Rho family
members is known to mediate several
aspects of cellular behavior, including
migration, by connecting cell surface
receptors to intracellular response
elements. In doing so, Rho GTPases
have been shown to regulate actin
remodeling, cell polarity, vesicular
trafﬁcking, and gene expression, all of
which are necessary for wound healing.
Speciﬁcally, RhoA has been shown
to induce stress ﬁber contraction and
focal adhesion formation at the trailing
edge, Rac1 is involved in the formation
of lamellipodial protrusions, whereas
Cdc42 induces ﬁlopodial protrusions at
the leading edge of the cell (Hall, 1992)
(Figure 1). In epidermal keratinocytes, it
now appears that there is a more complex
and a dynamic pattern of spatiotemporal
coordination of multiple cytoskeletal
components required for appropriate
rearrangement of the ﬁlaments that
ultimately result in directional cellular
migration. In the current issue, Char-
afeddine R et al. (Charafeddine et al.,
2015) describe new insights into the
mechanisms affecting the microtubule
network and cytoskeletal remodeling
during wound healing.
Microtubule network and directional
movement
As opposed to being polarized in the
direction of migration as occurs with the
actin cytoskeleton, the microtubule (MT)
network is polarized from the center to
the periphery of the cell (Figure 1). MTs
stem from the microtubule organization
center (MTOC) in both motile and static
cells, with the MTOC being able to
reorient itself toward the direction of
migration in motile cells (Wehrle-Haller
and Imhof, 2003). Because Cdc42 abla-
tion has been shown to disrupt MTOC
positioning, it can be argued that reor-
ientation of the MTOC is at least partly
controlled by microﬁlament–microtu-
bule interaction (Nobes and Hall,
1999). The importance of coordination
between MT and actin ﬁlaments for
wound healing has been demonstrated
by conditional targeting of the epidermal
ACF7, member of the spectraplakin
family (Wu et al., 2008). ACF7 deﬁ-
ciency resulted in impaired keratinocyte
motility and delayed wound closure, due
to defective coordination of MT growth
along F-actin ﬁlaments, emphasizing
signiﬁcance of interaction between MTs
and actin microﬁlaments for directional
cell movement.
The role of microtubule-severing
enzymes in cytoskeletal remodeling
and cellular migration
In order to function properly, MTs must
undergo constant remodeling to meet the
needs of the cell, either at the ends of
MTs or by being cut into short fragments,
a feat accomplished by microtubule-
severing proteins. There are three
members of ATP-dependent micro-
tubule-severing enzymes that have been
identiﬁed thus far––namely, katanin,
plastin, and ﬁdgetin. Apart from the
aforementioned role of cutting MTs into
small fragments, MT- severing proteins
are also involved in allowing transport of
MTs within the cell and seeding new MT
growth, as well as releasing MTs from
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their respective nucleation sites. Katanin
was the ﬁrst MT-severing enzyme to
be discovered, and, it was found to be
composed of KATNA1 and KATNB1,
both of which are highly conserved
evolutionarily (McNally and Vale,
1993). Katanin is thought to stimulate
cell growth by releasing MTs from
centrosomes and dissecting them into
smaller sections that can be used to seed
new MT growth. Furthermore, katanin
has been shown to have both pro- and
anti-migratory effects, where, on the
one hand, it promotes cell motility by
releasing MTs from centrosomes and
promoting their transport toward the
leading edge of some mammalian cells
(Figure 1), whereas, on other hand, it can
suppress MT polymerization and inhibit
migration in Drosophila (Zhang et al.,
2011). Spastin was discovered initially
as a regulator of hereditary spastic para-
plegia, and it has been shown to
be important in regulating mitosis,
meiosis, neural morphogenesis, and cell
migration (Hazan et al., 1999). Finally,
ﬁdgetin was discovered as responsible for
the murine “ﬁdget” phenotype, which
displays head shaking and circling,
combined with severe auditory, ocular,
and skeletal defects. Together with two
ﬁdgetin-like proteins (FL1 and FL2),
ﬁdgetin has been implicated as playing
roles in mammalian development, neural
morphogenesis, and mitosis by severing
MTs and suppressing their growth from
centrosomes (Cox et al., 2000).
In the current issue, David Sharp’s
group (Charafeddine et al., 2015)
provides evidence that FL2 also serves
as a regulator of keratinocyte and
ﬁbroblast migration by regulating
organization of the microtubular
cytoskeleton. It does so by shearing
MTs that associate with speciﬁc sites at
the cell cortex, which raises the
possibility of a role for FL2 in the cross
talk between MTs and the actin
cytoskeleton (Figure 1). Although the
actual mechanism by which FL2 inhi-
bits migration has yet to be determined,
it is possible that, similarly to katanin,
FL2 inhibits MT polymerization at the
leading edge of the migrating cell and in
that way prevents local activation of
Rac1, which is known to be involved in
lamellipodial protrusion. Furthermore,
the investigators demonstrate that FL2
depletion by siRNA increases the area
of focal adhesion, resulting in optimal
FA size, as is required for directional
migration. In the absence of severing by
FL2, microtubular ends may also grow
faster along the actin ﬁlaments, allowing
association with other cellular compo-
nents and more efﬁcient focal adhesion
turnover (Figure 1). It would be interest-
ing to assess the role MT severing by FL2
on spatiotemporal localization and the
activity of Rho GTPases, as well as their
upstream and downstream effectors dur-
ing wound closure. Also, the possible
role of FL2 on MTs at the trailing edge
remains unanswered, as it has been well
established that RhoA/Rac1 has opposing
effects in the leading and trailing edges of
polarized cells (Nobes and Hall, 1999).
More research is required to determine
the exact mechanism of how cytoskeletal
remodeling and microtubule severing by
FL2 affect directed cellular migration
during wound healing.
Topical siRNA delivery for improved
wound healing
Finally, Charafeddine R et al.
(Charafeddine et al., 2015) brought
their ﬁnding on novel FL2 functions
one step closer to clinical application.
Utilizing nanoparticles for siRNA
delivery, they achieved efﬁcient FL2
knockdown in vivo in murine full-
thickness excisional and burn wounds,
which resulted in a more rapid wound
closure. One of the major challenges in
transitioning from bench to bedside
for siRNA-based therapeutics in derma-
tology is the development of optimal
delivery systems that would achieve
efﬁcacy with minimal side effects. In
order to knock down the expression
of target genes in the skin, the siRNA
delivery vehicle must be able to pene-
trate the cutaneous barrier and then
carry siRNA into the target cell where
it can enter the RNAi pathway in the
cytosol. Although unlikely to penetrate the
intact stratum corneum, signiﬁcant uptake
of nanoparticles and efﬁcient siRNA
delivery may occur when the barrier is
broken. A recent study has documented
effective siRNA-nanoparticle delivery
into diabetic murine wounds with the
same goal: accelerated wound closure.
Namely, spherical nucleic acid gold
nanoparticles were used successfully to
knock down ganglioside-monosialic
acid 3 synthase (GM3S) in a diabetic
mouse wound model, which, similarly to
FL2 knockdown, resulted in enhanced
migration and improved wound healing
(Randeria et al., 2015). Assuming confor-
mation of FL2 and/or GM3S upregulation
in patients with non-healing wounds,
siRNA-nanoparticle targeting of these
genes may offer safe and effective local
therapy for chronic wound disorders.
However, all non-healing wounds and
burns are moderately to highly colonized
with bacteria and fungus (Pastar et al.,
2014), and, therefore, the efﬁciency of
siRNA therapies targeting cell migration
may be reduced. In addition to siRNA
delivery, the ideal nanoparticles should
provide sustained release of antimicro-
bials to inhibit the proliferation of patho-
gens, while simultaneously accelerating
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Figure 1. Cytoskeletal remodeling during directional cell migration and the role of microtubule (MT)-
severing protein FL2. Fidgetin-like 2 (FL2) depletion stimulates keratinocyte and ﬁbroblast migration by
increasing the focal adhesion area (FA) through an unknown mechanism, possibly linking MTs, actin, and
MT-severing proteins to focal adhesion turnover. The role of MT- severing proteins including FL2 at the
trailing edge of the migrating cell has yet to be determined.
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such as dendrimers were shown to be an
effective way of delivering Ambisome, an
antifungal drug, for treating cutaneous
Leishmaniasis in a mouse model that
included reduced drug toxicity (Daftarian
et al., 2013). Nitric oxide–loaded nano-
particles have shown promising anti-
microbial activity in a murine wound








An important feature of nanocarriers
is the ability to cause “triggered release”
of siRNA/drugs in speciﬁc target tissues
and target cells and even in response to
environmental signals. Considering the
dynamics of the wound healing, nano-
delivery technologies, including siRNA
nanoparticles, spherical nucleic acid
gold nanoparticles, and dendrimers,
offer the promise of controlled and
targeted delivery for maximizing ther-
apeutic effectiveness.
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PLCG1 Gene Mutations in Cutaneous
T-Cell Lymphomas Revisited
Cornelis P. Tensen1
The observation that mutations in the phospholipase C gamma 1 (PLCG1) gene
(among which p.S345F was shown to be activating) are frequent (20%) in tumoral
cutaneous T-cell lymphoma (CTCL) samples raised the possibility of targeting
therapies against the PLCG1 signaling pathway. However, new data by Caumont
et al. in this issue of JID show that PLCG1 mutations are far less prevalent than
expected in CTCLs, which tempers the initial enthusiasm. This new study ﬁnds
that only 3–5% of the CTCL tumor genomes (mycosis fungoides and Sézary
syndrome) harbor PLCG1 mutations.
Journal of Investigative Dermatology (2015) 135, 2153–2154; doi:10.1038/jid.2015.221
Despite many (recent) efforts, the mole-
cular events driving the genesis of
cutaneous T-cell lymphomas (CTCLs)
remain largely unknown. Genome-wide
and more focused approaches have
revealed the existence of recurrent
chromosomal or genetic alterations,
some of which also have potential
diagnostic and/or prognostic value
(e.g., Vermeer et al., 2008; Caprini
et al., 2009; van Doorn et al., 2009;
Salgado et al., 2010; Laharanne et al.,
2010a, b; Nicolae-Cristea et al., 2015).
However, until recently, no speciﬁc
genetic alterations have been identi-
ﬁed that, in the short term, may beneﬁt
the management of patients with CTCLs
(e.g., yielding potential pharmaceutical
targets).
A publication in Blood by Vaqué et al.
(2014) held the promise of breaking this
impasse by reporting that, in about 20%
of patients with epidermotropic CTCLs,
the malignant cells bore somatic muta-
tions in the phospholipase C gamma 1
(PLCG1) gene. Even more importantly,
the investigators showed that one of
the recurrent mutations (the p.S345F
mutation) conferred an enhanced signal-
ing capacity and transforming property
toward the mutated PLCG1 protein.
This active form of PLCG1, speciﬁcally
expressed by the tumor cells, thus, is
emerging as an attractive therapeutic
1Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
Correspondence: Cornelis P. Tensen, Department of Dermatology, Leiden University Medical Center,
Einthovenweg 20, Leiden 2333ZC, The Netherlands. E-mail: c.p.tensen@lumc.nl
COMMENTARY
www.jidonline.org 2153
